[HTML][HTML] Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCC

Y Zhang, S Liu, D Qu, K Wang, L Zhang, X Jing, C Li… - Scientific reports, 2017 - nature.com
Y Zhang, S Liu, D Qu, K Wang, L Zhang, X Jing, C Li, F Wei, X Qu
Scientific reports, 2017nature.com
Crosstalk between tumor infiltrating macrophages and tumor cells is thought to play an
indispensable role in oral squamous cell carcinomas (OSCC) by induction and maintenance
of tolerance microenvironment. High infiltration of M2 macrophages and increasing
expression of Kinesin family member 4A (Kif4A) in primary OSCC have been proved to
correlate with greater tumoral size and poor clinical outcome. However, linkage between
Kif4A and infiltrating macrophages in tumorigenesis and progression remains unclear. In the …
Abstract
Crosstalk between tumor infiltrating macrophages and tumor cells is thought to play an indispensable role in oral squamous cell carcinomas (OSCC) by induction and maintenance of tolerance microenvironment. High infiltration of M2 macrophages and increasing expression of Kinesin family member 4A (Kif4A) in primary OSCC have been proved to correlate with greater tumoral size and poor clinical outcome. However, linkage between Kif4A and infiltrating macrophages in tumorigenesis and progression remains unclear. In the present study, we show that, the interaction between THP-1derived macrophage and OSCC cell line Cal-27 may up-regulate the Kif4A expression in both of them. Additionally, elevated soluble CCL2 in medium and more expression of CCR2 on macrophage were observed during the crosstalk. SiRNA of Kif4A and neutralizing antibody of CCL2 were utilized to identify that; increasing Kif4A can promote the recruitment of macrophages towards Cal-27 and educate them to M2 polarized macrophages via regulating CCL2/CCR2. In combination, the results of the present study may provide interesting clues to understanding the Kif4A-CCL2/CCR2-macrophage axis as a novel therapeutic target to improve the clinical outcome of OSCC.
nature.com